A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Summary

The goal of this clinical trial is to learn more about the side effects and best dose of AXN-2510 in adults with advanced solid tumors. The main questions it aims to answer are: * What are the side effects of AXN-2510? * Which is the best tolerated dose of AXN-2510? * How long does AXN-2510 stay in your body? Participants will receive AXN-2510 every 3 weeks. Participants will visit the clinic for checkups and tests several days during the first and third doses, and once every 3 weeks for other doses.

Timeline

Start

2025-09-15

Primary completion

2026-04-16

Completion

2026-04-16

Outcome

Outcome not reported

Stopped: “The study was terminated early due to discontinuation of development of the investigational program.”

Drugs

Indications